GAMMA Investing’s Soleno Therapeutics SLNO Stock Holding History

GAMMA Investing’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-116	Closed	-$3.88K	–	4220
2026 Q1	$3.88K	Sell	116 -11	-9%	-$431	﹤0.01%	3459
2025 Q4	$5.88K	Buy	127 +41	+48%	+$2.25K	﹤0.01%	3215
2025 Q3	$5.81K	Buy	86 +8	+10%	+$593	﹤0.01%	3114
2025 Q2	$6.54K	Buy	78 +31	+66%	+$2.32K	﹤0.01%	3014
2025 Q1	$3.36K	Sell	47 -28	-37%	-$1.36K	﹤0.01%	3237
2024 Q4	$3.37K	Buy	75 +18	+32%	+$933	﹤0.01%	3058
2024 Q3	$2.88K	Buy	+57	New	+$2.73K	﹤0.01%	2946

GAMMA Investing's SLNO Position: Q2 2026 in Review

GAMMA Investing sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 116 shares — an estimated $3.88K sold.

GAMMA Investing first reported a position in SLNO in Q3 2024 and held it in 7 quarters. The position peaked at $6.54K in Q2 2025. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

GAMMA Investing reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
GAMMA Investing sold 116 Soleno Therapeutics shares in Q2 2026, an estimated $3.88K.
GAMMA Investing first reported a position in Soleno Therapeutics in Q3 2024 and held it in 7 quarters.
GAMMA Investing's Soleno Therapeutics position peaked at $6.54K in Q2 2025.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.